Merck and Moderna’s Intismeran Autogene Plus Keytruda Meets Phase 3 RFS and DMFS Endpoints in Resected Melanoma
FDA Grants HDE Approval to OncoSil for Distal Cholangiocarcinoma
FDA Lists More Than 1,500 AI-Enabled Medical Devices as Oncology Applications Expand
Simplify Your ESO College Enrolment With Our New 3-Year Plan - ESO
Human Connection in Cancer Care with Dr. Aleksandra Filipovic - CancerWorld
oncoHUB and OncoDaily Announce Strategic Partnership to Strengthen Ukrainian Oncology
Bridging the Care Gap: Expanding Humanitarian Access to CLL Treatment Across LMICs
ENZAMET: Enzalutamide Maintains Long-Term Survival Benefit in mHSPC
The SOHO 2026 Fourteenth Annual Meeting, organized by the Society of Hematologic Oncology (SOHO), will take place on 9–12 September 2026 at the George R. Brown Convention Center in Houston, […]
